Climate change and cascading risks from infectious disease

JC Semenza, J Rocklöv, KL Ebi - Infectious diseases and therapy, 2022 - Springer
Climate change is adversely affecting the burden of infectious disease throughout the world,
which is a health security threat. Climate-sensitive infectious disease includes vector-borne …

RTS, S/AS01 vaccine (Mosquirix™): an overview

MB Laurens - Human vaccines & immunotherapeutics, 2020 - Taylor & Francis
Malaria is an illness caused by Plasmodium parasites transmitted to humans by infected
mosquitoes. Of the five species that infect humans, P. falciparum exacts the highest toll in …

Emerging concepts and technologies in vaccine development

M Brisse, SM Vrba, N Kirk, Y Liang, H Ly - Frontiers in immunology, 2020 - frontiersin.org
Despite the success of vaccination to greatly mitigate or eliminate threat of diseases caused
by pathogens, there are still known diseases and emerging pathogens for which the …

Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects

AA El-Moamly, MA El-Sweify - Tropical Medicine and Health, 2023 - Springer
Background The world has made great strides towards beating malaria, although about half
of the world population is still exposed to the risk of contracting malaria. Develo** an …

Malaria vaccines: progress to date

DI Stanisic, MF Good - BioDrugs, 2023 - Springer
Malaria is a mosquito-borne disease caused by protozoan parasites of the genus
Plasmodium. Despite significant declines in malaria-attributable morbidity and mortality over …

[HTML][HTML] Vaccine adjuvants: from 1920 to 2015 and beyond

A Di Pasquale, S Preiss, F Tavares Da Silva, N Garçon - Vaccines, 2015 - mdpi.com
The concept of stimulating the body's immune response is the basis underlying vaccination.
Vaccines act by initiating the innate immune response and activating antigen presenting …

Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children

A Olotu, G Fegan, J Wambua… - … England Journal of …, 2016 - Mass Medical Soc
Background The candidate malaria vaccine RTS, S/AS01 is being evaluated in order to
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …

Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine

DE Neafsey, M Juraska, T Bedford… - … England Journal of …, 2015 - Mass Medical Soc
Background The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Beyond antigens and adjuvants: formulating future vaccines

TJ Moyer, AC Zmolek, DJ Irvine - The Journal of clinical investigation, 2016 - jci.org
The need to optimize vaccine potency while minimizing toxicity in healthy recipients has
motivated studies of the formulation of vaccines to control how, when, and where antigens …

Childhood adiposity, adult adiposity, and cardiovascular risk factors

M Juonala, CG Magnussen, GS Berenson… - … England Journal of …, 2011 - Mass Medical Soc
Background Obesity in childhood is associated with increased cardiovascular risk. It is
uncertain whether this risk is attenuated in persons who are overweight or obese as children …